A prominent 19kOa surface antigen of Legionella pneumophila, cloned in Escherichia coli, was found to be intimatety associated with peptidoglycan. The DNA region encoding this antigen was mapped on an 11.9kb plasmid by means of detetion analysis and transposon mutagenesis. The presence of a signal sequence of 22 amino acids with a consensus sequence for cleavage by signal peptidase II indicates that the antigen is a lipoprotein, and striking similarity with peptidoglycan-associated tipoproteins (PALs) from E. coli (51% amino acid homoiogy) and Haemophilus influenzae (55% homology) is noted. We conclude that the 19kDa antigen of L. pneumophila is the structural equivalent of the PAL found in other Gram-negative species and suggest that its post-translational acylation may explain its potency as an immunogen.
Introduction
We previously described the cloning of a 19000Da (19kDa) antigen of Legionella pneumophila and subsequently showed that this protein is accessible to serum antibodies on the surface of both L. pneumophila and Escherichia coli clones carrying the gene for this antigen on a multicopy plasmid, pSMJ11 b) . All L. pneumophila strains that vi/e have tested express this antigen, and strains of several other Legionella species express a smaller, cross-reactive protein of-18kDa (Engleberg e/a/., 1986) . In polyacrylamide gels, the 19kDa L pneumophila antigen nearly comigrates with the E. coli peptidoglycan-associated lipoprotein (PAL). Both the L. pneumophila protein and the comigrating E. ooli PAL produce a 'tailing' phenomenon in polyacrylamide gels that is typically associated with Itpoproteins. Peptldogtycan-associated lipoproteins similar to the £ coli PAL have been identified in several Gram-negative bacterial species (Mizuno, 1981; Delch et ai. 1990 ), and we hypothesized that the 18-19 kDa Legionella antigens might be homologues of these lipoproteins, Although the functional role of the small, peptidoglycanassociated lipoproteins remains unproven, it is assumed that these molecules have a structural role, providing anchorage between the cell wall and the outer membrane. These molecules are of interest in pathogenic bacteria, because they may be potent B-cell mitogens and immunoadjuvants (Melchers etai. 1975; Lex etai, 1986) . Moreover, because they are primarily localized to the outer membrane, they may be accessible to specific antibodies on the bacterial surface. The Haemophilus influenzae PAL has been shown to be a target for bactericidal antibodies and may be regarded as a potential vaccine candidate (Greene/a/., 1987) .
In this communication we present the D^4A sequence of the 19 kDa L. pneumophila antigen gene. Its inferred amino acid sequence data confirm the presence of a signal for acylation and a high degree of amino acid homoiogy with other known PAL sequences. We conclude that this protein is a homologue of the previously sequenced E. coli and H. mfluemae pal genes (Chen and Henning, 1987; Deich etai. 1990) .
Results

Peptidoglycan association of the 19kDa antigen
In a previous study, we showed that the L. pneumophila major outer membrane protein (MOMP) is peptidoglycanbound by first heating bacteria in 2% sodium dodecyl . L micdadei antiserum was used in this experiment to minimize background and to limit the number of visuaiized antigens. Immunoblots of bacteriai lysates with homologous antisera produce a background reactivity wHh iipopolysacchande (LPS). L micdade/antisefum has no detectable LPS cross-fBactlvity, but it has strong cross-reactivity wtth the 19kDa antigen and several other L pneumophila proteins, i-anes; a, supernatant from bacteria boiled in 2% SDS for 2 min; b, insoluble pellet from lane a samples washed and reboiled in 2% SDS for 5 min; c, insoluble pellet washed and reboiled in 4% SDS for 5 min.
sulphate (SDS) for 2 min, recovering the insoluble pellet by centrifugation, and subsequently releasing the MOMP from the pellet by reheating to 100°C for 10 min in 2% SDS with 5% 2-mercaptoethanol (Engelberg et ai. 1989) . In that experiment, immunoblots of the peptidogiycan-associated proteins with Legionella immune serum showed that the predominant antigen released from the insoluble pellet was 19 kDa in size. To confirm that this peptidogiycan-associated antigen is identical to the one encoded on pSM J11, we repeated this experiment and immunobiotted the peptidogiycan-associated fraction with immune sera and with a monoolonal antibody (mAbi E9) that reacts with the cloned antigen. The immunoblot shown in Fig. 1 confirms that much of the 19kDa antigen is associated with peptidoglycan, since a significant proportion is retained with the insoluble pellet after most other bacterial proteins are solubilized. The reactivity of the antigen with mAb1E9 in both soluble and insoluble fractions confirms the identity of this protein.
Subcioning of the 19kDa antigen gene
The 19kDa antigen was originally cloned on plasmid pSMJII (Engleberg et ai, 1984a) . Various restriction fragments were deleted from the insert in pSMJ11, and the resulting clones were tested for expression of the 19 kDa antigen ( Fig. 2A) . The ~3.75kb insert of pSMJ11.4 was the smallest of the fragments that still expressed the antigen. Either of two deletions within the pSMJ11.4 insert (made at unique Sph I and Aval sites using S1 nuclease digestion and blunt-end ligation) abrogated expression of the 19kDa antigen, suggesting that these mutations may disrupt a reading frame that is critical for antigen expression.
To be able, eventually, to mobilize the cloned gene from E. coli into L. pneumophila. the insert expressing the 19kDa antigen was cloned into a vector with an antibiotic resistance marker that is selectable in L. pneumophila. i.e. pTLP5 (chloramphenicol-resistant. Cm"; streptomycinsensitive, Sm^). Accordingly, the EcoRI-Pvull fragment of pSMJ11.4 was first ligated to pUCI 6 digested with EcoRI and Smal. This manipulation allowed for the positioning of the SamHI site of the pUC18 multiple cloning site next to the PvuW-Sma I junction at which the insert and vector are joined. The large SamHI-Sc/l fragment of this intermediate plasmid was then isolated and cloned into the unique SamHI site of pTLP5 to yield pDH11.2. Immunoblotting experiments confirmed that the 19kDa antigen Is expressed from pDH11.2 to the same degree as from pSMJ11.4 (data not shown).
Mutagenesis of a DNA fragment encoding the 19kDa antigen with TnphoA
In Initial experiments with transpositional mutagenesis, TnpAjOiA-1 was inserted into the fragment of interest on pSMJ11.4. In later experiments, Tnp/io-4-onTwas inserted into the slightly shorter fragment on pDH11.2. This second set of transposon insertions was generated in anticipation of future experiments (now in progress) in which the mutated genes on these plasmids will be transferred to L. pneumophila and exchanged for the native genes. In all transposition experiments, E coli CC118 carrying the relevant plasmid was infected with either XTnp/ia4-1 or \::Jr\phoA-oriTand plated on LB/XP media containing kanamycin (200 or 300|xg ml"'). Plasmid minlpreps were prepared from individual transductants that appeared blue (i.e. PhoA*^) and were used to retransform strain CC118. If the transconjugants were all PhoA* on media with XP, then the plasmid was assumed to have acquired a phosphatase function and was analysed using restriction endonucleases. Each transposition yielding a PhoA fusion was designated by the letter B (for 'blue') followed by an individual number (given in Fig. 2B ). Several kanamycin-resistant transductants that were PhoA" were likewise analysed to identify random inphoAoriT insertions in pDH11.2. These transpositions were designated by the letter W (for 'white') followed by an individual number. Within the -3500bp insert of pSMJ11.4 and pDH11.2. PhoA' gene fusions were limited to a -IBOObp region, and all transpositions giving productive fusions were oriented in the same direction (Fig. 2B) . Several of these transpositions were clustered near the Ava\ and SphI sites, previously shown to be cntical for the expression of the 19kDa antigen. Clones carrying transpositions B-16, B-17, and all transpositions between, failed to react with mAbi E9 by dot immunoblot analysis. In addition, Western blot analysis of some of these clones using Legionella immune serum shovi/ed that the 19 kDa antigen was absent and that new antigenic bands of >47 kb, presumably fusion proteins, were present instead {Fig. 3, panel A). Fusions downstream of B-17 did not affect expression of the 19kDa antigen. We inferred from these findings that the region defined by gene fusions B-16 to B-17 resents the gene encoding the 19 kDa antigen.
An additional cluster of PhoA* fusions was mapped to a -lOOObp region immediately downstream from the 19kDa antigen gene (Fig. 2B ). The clones carrying the fusions from B-25 to B-28 were reactive with mAbi E9 and all of those tested expressed the 19kDa antigen on Western blots with Legionella immune serum. Western blot analysis of several of these clones with alkaline phosphatase antiserum showed fusion products of increasing size (from ~69 to -88kDa) corresponding to the point of the transposon insertion, i.e. as the transposon insertions mapped further downstream, the fusion products were larger (Fig. 3, panel B ). This analysis suggests that the cloned region immediately downstream from the 19kDa antigen gene contains another gene encoding a single secreted protein.
Rnally, 22 Jr\phoA-oriT transprasitions that did not produce gene fusions were mapped within the pDH11.2 insert fragment (Fig. 2B ). These transpositions were randomly distributed within the fragment, except for a region of ~750bp immediately upstream of the 19kDa antigen gene, into which no transpositions were isolated.
DNA sequence of the 19kDa protein antigen
The two Sphi-Pst\ fragments representing the upstream and downstream portions of the 19 kDa antigen gene, as well as a Sau3A fragment that spans the internal Sph I site, were isolated and cloned into the replicative form of both M13mp18 and M13mp19. Single-stranded templates of the resulting phages were purified and sequenced as described below. The first 140bp of sequence are derived from a single strand and therefore should be considered tentative. All remaining portions of the sequence were derived from primer extension on both strands using overlapping templates. The DNA sequence obtained from these M13 subclones is shown in Fig. 4 . Three long open reading frames were identified, all of which would be transcribed in the same direction as the TnphoA gene fusions. One of the open reading frames (528bp) spans the region to which the 19 kDa antigen gene was mapped (Fig. 2C) . An upstream open reading frame {orfU) of at least 309bp begins upstream of the boundary of the sequenced fragment and terminates 101 bp before the beginning of the 19kDa gene. A downstream open reading frame {orfD) of at least 613bp begins 1 bp before the termination codon of the 19 kDa antigen gene (i.e. the sequence is ... ATGA . . .} and extends beyond the boundary of the subcloned fragment. The ATG codon that begins the 528 bp reading frame {at nucleotide 410 in Fig. 4 ) is preceded by a consensus Shine-Dalgamo sequence 8bp upstream, strongly suggesting that this codon represents a translationai initiation site (Stormo et ai, 1982) . There is no obvious consensus promoter sequence upstream of this initiation site (Mulligan etai. 1964) . The reading frame encodes a poiypeptide of 176 amjno acid residues having a molecular weight of 18913Da.
Lpn. H.ml.
Because our characterization of the 19 kDa antigen suggested that it was peptidoglycan-bound and that it might be a lipoprotein, we compared the inferred amino acid sequence of this gene with that of the previously sequenced E. coli and Haemophilus influenzae peptidoglycan-bound lipoproteins (PALJ {Chen and Henning. 1987; Deioh et ai. 1990) . With inclusion of conservative substitutions, the comparison revealed 51 % and 55% homoiogy between the 19 kDa antigen and the £ ooli and H. influenzae pal gene products, respectively (Fig. 5) . The most striking similarity was observed in the carboxy-terminal half of the proteins, which includes the peptidoglycan-binding domain (66% and 61% homoiogy. respectively). All three sequences have putative signal sequences terminating at a cysteine residue (at residue 22 in E. coli and L. pneumophila and at residue 20 in H. influenzae). At these positions, there is also strong conformity with a consensus sequence for signal peptidase II {Leu-Ala/Ser-Gly/Ala-Cys). which is found in about threequarters of all bacterial lipoproteins studied {Hayashi and Wu. 1990). Both the E co// and L. pneumophila sequences have conserative substitutions at the -3 position; however, Leu is strictly conserved at this position in only 75% of all sequenced lipoproteins. All three sequences have Ser at position +2, a feature of 38% of all bacterial lipoproteins {Hayashi and Wu, 1990). Given these striking sequence similarities, we conclude that the 19 kDa antigen of L. pneumophila is a homologue of the E. coli lipoprotein and from now on we will refer to this L. pneumophila gene as pai
Partial analysis of the genes flanking pal
It was apparent from the analysis of PhoA gene fusions that the long open reading frame downstream of pal. orfD, also encodes a secreted protein. orfD has several in-frame methionine codons, but the only one preceded by a possible Shine-Dalgarno sequence is the ATG codon that overlaps with the termination codon of pal (at nucleotide 937). Using a partial amino acid sequence inferred from orfD, we searched the protein data bank for similarities with previously registered sequences. No extensive homoiogy with a known protein sequence was uncovered. A similar analysis of the other partial amino acid sequence inferred from orfU also failed to yield any useful insights.
Eurther subcioning of the 19kDa protein antigen gene
Because the region upstream of pal was devoid of transpositions from a point approximately 400bp upstream from the 5' end of our sequenced region to the 3' end of orfU (Fig. 2) , we speculated that orfU may be an essential gene when pal and/or the downstream genes are cloned in multiple copies. If so, orfU might encode either a transoriptional repressor of pal {and other downstream genes) or a protein that interacts post-translationally with the products of pal and/or other genes to assure their appropriate expression. All the subclones we had generated, including the M13 derivatives prepared for sequencing, carried either fragments of pal or an intact copy of pal with the transpositional ly silent, upstream region.
To determine whether pal could be expressed independently of orfU, we attempted to subcione the 1333bp Pst\-Xho\\ fragment of pDH11.2 that carries the entire pal gene and the 3' end of orfU (Fig. 2B) by ligating it into the pBR322 derivative, pJAI, afier digestion with BamHl and Nsi\. After several attempts to do this had failed, we repeated the ligation reaction and then transformed competent £ co/zHBIOI and HB101{pDH11.2::Tnpha4-onT.B-16) in parallel. Phenotypically, the latter strain is Km" (kanamycin-resistant). Cm", PhoA"^, and PAL . and the plasmid (which we will abbreviate in further references as 'pDH11.2::B-16') includes an intact orfU region. As expected, there were no ampicillin-resistant {Ap'') transfonmants of HB101: however, using the same amount of the same ligation mixture, there were 53 Ap" transformants of HB101{pDH11.2::B-16), two of which were also PAL*. One of the PAL* isolates contained two ptasmids: one was the size of pDH11.2::B-16, and the other was the size predicted for the pJAI-pa/ hybrid plasmid. When this isolate was passed on streptomycincontaining media to counterselect pDH11.2::B-16 (which carries rpsL (Sm^ allele), 30 colonies were screened and found to be Cm^, Km", and Ap"; all 30 were PAL'. The original PAL* isolate and the Sm" isolates were unstable and became PAL with passage, in spite of continued selective pressure with ampicillin, and they lost all detectable plasmid DNA. The second of the two PAL* transformants carried a single plasmid intermediate in size between pDH11.2::B-16 and the pJAI-pa/hybrid. Streptomycin-resistant derivatives from this isolate were Cm®, Km^. Ap", and PAL*. This isolate and its derivatives were also highly unstable with respect to PAL reactivity and continued presence of plasmid DNA.
Discussion
These studies demonstrate that the 19kDa surface antigen is the peptidogiycan-associated lipoprotein of L. pneumophila. The label 'peptidogiycan-associated lipoprotein' was first applied to certain matrix proteins of Pseudomonas aeruginosa and f. coli (Mizuno. 1979) . These molecules were characterized by their retention on the cell wall in 2% SDS at 35*'C. by labelling with [^^C]-palmitic acid and 2-[^H]-glycerol, and by biochemical separation from the covalently bound mureinlipoprotein described by Braun {Mizuno, 1979; Braun. 1975) . Subsequently, similar lipoproteins were found in Proteus mirabilis and a wide variety of Gram-negative organisms {Mizuno, 1981). Even before DNA sequencing, we suspected that this was also the identify of the L pneumophila 19kDa antigen because of its comigration of the £ coli PAL, the non-covalent but strong association with the cell wall, and the tailing phenomenon associated with this protein band in Western blots.
DNA sequencing was directed at a small region of the cloned insert of pSMJli that had been identified as the gene encoding the antigen by deletion analysis and transposon mutagenesis. The isolation of PhoA* fusions within this gene again confimed that its product is a secreted polypeptide. An open reading frame, beginning with a consensus initiation codon, was found in the appropriate map position and correct orientation.
The sequence of the putative open reading frame encodes a protein with extensive homoiogy to the pal genes of both E coli and H. influenzae. The degree of homoiogy is roughly comparable between any of the three sequences, particularly in the C-terminal half of the protein that is known to include the peptidoglycan-binding domain (Mizuno et ai. 1982) . In addition, the L pneumophila protein t>egins with a signal sequence of 22 residues that ends with a consensus cleavage site for signal peptidase II. The presence of these features in an amino acid sequence has been generally considered sufficient evidence to characterize the sequence as a lipoprotein (Hayashi and Wu, 1990) . This finding, combined with the physical characteristics of the protein and the sequence homology. leave no doubt as to its identity as the L. pneumophila PAL.
PAL is one of the most potent immunogens of L pneumophila. Its prominence as an antigen probably explains why it was so readily cloned in our early experiments and in experiments by others who also screened an £ CO//genomic library with Legionella immune serum. The reason for its immunogenicity may relate to its lipoproteinaceous nature. The Braun lipoprotein has long been known to be a B-cell mitogen (Melohers et ai. 1975) , and its mitogenicity can be reproduced by various synthetic lipopeptides that mimic its A/-terminus (Wiesmuller ef al., 1983) . The synthetic analogues differ from lipoprotein W-temiini only in that their lipid components are uniformly composed of palmitic acid. The tripalmitoyi dipeptide /S^palmitoyl-S-(2,3-bis(palmitoyloxy) -(2RS) -propyO-(fl)-cysteine-serine (or Pamg-Cys-Ser) is as potent a polyclonal B-cell activator as longer lipopeptide analogues (Prass et ai. 1987) . This is noteworthy since this lipropeptide may also mimic the A/-terminus of the L. pneumophila PAL.
In addition to their mitogenicity, synthetic lipopeptide analogues have also been shown to act as potent immunoadjuvants {Lex et ai. 1986). A significant adjuvant effect was recently demonstrated for the lipotripeptide Pam3-Cys-Ser-Lys-, covalently bound to the hapten. dinitrophenol (Reitermann et ai, 1989) . Again, this analogue mimics the L. pneumophila PAL sequence. Similar synthetic analogues have been shown to activate macrophages and to induce the production of IL-1, IL-6. and TNFa {Hauschildt etai, 1990) .
The implications of these lipoprotein properties for bacterial infections are speculative. However, immunogenic surface proteins from a variety of pathogenic bacteria are now known to be lipoproteins. These include the H.8 outer membrane protein of the pathogenic Neisseria species (Cannon, 1989) , the P6 protein (or PALj of H. influenzae (Murphy et ai, 1986) . the Braun lipoprotein analogue of Brucella abortus (Gomez-Miguel et ai, 1988) , OspA and OspB of Borrelia burgdorferi{Bergstrom etai. 1989) . and the 34kDa membrane protein of Treponema pallidum (Swancutt et ai, 1990) . The H. influenzae PAL has been shown to be a target for bactericidal antibody, even in type b encapsulated strains (Green et ai, 1987) . This conserved molecule is therefore a potential vaccine candidate. Likewise, monoclonal antibodies directed against this PAL have been useful in non-culture diagnostic methods for H. influenzae {Groeneveld ef ai, 1989). Whether or not the L. pneumophila PAL will prove similarly useful for preventive or diagnostic use against Legionnaires' disease is open to investigation.
The upstream partial open reading frame, which we have temporarily designated as orfU. seems to be required for the maintenance of pal in multiple copies. We were never able to isolate a transposition into this gene on a plasmid that contains pal, and we were never successful in cloning pal apart from orfU. We succeeded in isolating orfU and pal to separate replicons in the same strain; however, these constructs were exceedingly unstable. We speculate that £ coli may not tolerate multiple, isolated copies of pal and that the orfU region may exert a necessary moderating effect, e.g. by encoding a negative transcriptional regulator or a protein that effects PAL at the post-translational level. Transcriptional analysis of pal will resolve this issue.
It is unknown whether PAL has a role in the pathogenesis of Legionnaires' disease. As a possible mitogen and immunoadjuvant. it may influence disease by modulating the immune response. Alternatively, certain bacterial membrane lipoproteins, e.g. TraT, have been found to interfere with complement deposition, increase bacterial serum resistance, and marginally improve the growth of Salmonella typhimurium in a mouse model of infection {Rhen and Sukupolvi, 1988). More recently, genes encoding membrane iipoproteins that confer serum resistance in Vibrio choterae were found to be activated by the global regulator of virulence in that species (ToxR; Parsot e( a/., 1991). Whether or not PAL participates in serum resistance of L pneumophila or in other aspects of virulence is entirely speculative, but these questions might be addressed by generating isogenic pat~ mutants or by manipulating the expression of PAL in L. pneumophila. In this study, several transferable plasmids were constructed with insertion mutations in pat or orfD that can be used for allelio exchange experiments in L. pneumophila.
Experimental procedures
Bacterial and plasmids L. prieumophila AA^ 00 is a clinical Isolate that retains a high level of virulence for cultured macrophages and guinea-pigs. L pneumophila AA103 is a nalidixic acid-and streptomycin-resistant derivative of AA100. L pneumophila strains were grown on buffered charcoal yeast extract agar supplemented with a-ketoglutarate (BCYE-a) (Edelstein. 1982 pSMJ11 is a derivative of pBR322 that has a 7.5kb fragment from L pneumophila AA100 cloned in the SamHi site. pJA1 is a derivative of pBR322 that carries a unique multiple cloning site and which was designed and constructed in this laboratory. pTLP5 was also constructed in this laboratory (by J.A.) for the purpose of gene transfer to L. pneumophila. This plasmid carries the same multiple cloning site as pJA1. Further details of its construction will be reported elsewhere; however, for the purposes of this study, it is necessary to know that pTLP5 carries the chloramphenicol acetyltransferase gene of pACYC184, which is selectable in L pneumophila, and the E. coli rpsL allele, which confers streptomycin sensitivity In L. pneumophila strain AA103.
JnphoA-onTwas generated by insertion of an origin of transfer from the IncP group of conjugative plasmids into the SamHI site of Tnp/joA {Manoil and Beckwith. 1985); this insertion inactivates the cryptic Sm'^ gene of JnphoA. Details of this construction will be presented elsewhere (J. Arroyo, in preparation). PhoA fusions were screened by growing colonies on LB media with 40 jig mi"' of 5-bromo-4-choro-3-indolyl phosphate p(P).
Antibodies and sera
Rabbit antisera were prepared by subcutaneous injection with heat-killed L pneumophila or L micdadei at biweekly intervals for 6 weeks. Anti-alkaline phosphatase senjm was prepared by injection of £ co//alkaline phosphatase {Sigma Chemical Co.) in complete Freund's adjuvant initially and in incomplete Freund's adjuvant for booster immunizations.
Monocional antibody 1E9 is a mouse monoclonal antibody generated by immunization with crude outer membrane fractions of L. pneumophila. To avoid production of antibodies to lipopolysaccharide. fractions for booster immunizations were isolated from L pneumophila of diverse serogroups. Reactivity of mAb-1E9 with the native and cloned PAL antigen from AA100 was confirmed by immunoblotting; mAbi E9 also reacts with a 19kDa antigen in other L. pneumophila strains representing serogroups 1-8, but has no reactivity with any proteins of L micdadei or E. coli. by immunoblot analysis or dot immunoassay of whole bacteria.
Gel electrophoresis and immunoblotting
Bacterial pellets were lysed and proteins were solubilized by boiling in 2% SDS. 5% 2-mercaptoethanol. 50mM Tris-HCI (pH 6.8) for 2-5 min in different experiments. Insoluble material was removed by centrifugation at 12000 x gfor 5 min before loading of samples. In experiments requiring re-extraction of the cell-wall material, the insoluble pellet was washed once in water, then re-extracted as described. SDS lysates were separated by polyacrylamide gel electrophoresis (Laemmli. 1970) . Proteins were electrotransferred to nitrocellulose membranes over 3 h at 40 volts in Tris-glycine buffer with 20% methanol (pH 8.3). Enzyme immunoassays were performed on blots in 50 mM Tris-buffered saline {pH 7.5) with 0.05% Tween-20 (T-TBS). T-TBS was made with 500 mM NaCI for assays with immune serum and at 150 mM NaCI for assay with mAb1E9. After one hour of blocking in T-TBS. diluted immune sera or neat mAb1E9 hybridoma supematants were incubated with blots overnight. After three washes in T-TBS. blots were then incubated for one hour in horseradish peroxidase-conjugated goat anti-rabbit or anti-mouse immunoglobulins (Cappel Laboratories). After three final washes, peroxidase activity was detected using 0.06% diamlnobenzidine {Sigma Chemical Co.) in 0.003% hydrogen peroxide.
Subcioning
Plasmid DNA was isolated by the alkaline lysis method (Bimboim and Doly. 1979) . Restriction fragments for subcioning were isolated from agarose gels by electrophoresis onto DEAE membrane {Schleicher & Schuell) and eluted into high-salt buffer as described {Uzardi et ai. 1984). Ligation and transformation of CaCb-treated E coli were performed using standard methods {Sambrook otal., 1989).
Transposon mutagenesis
£ cxjii strains carrying plasmids with target sequences were transduced to kanamycin resistance with kJnphoA-^ or K::TnphQA-oriT. Plasmids were then isolated and introduced into CC118 by transformation or were transferred conjugally (in the case of Tnp/ja4-ori71 using a helper strain with conjugative plasmid pRK212.1. If transpositions mapped to the plasmid, the plasmid was isolated by the alkaline lysis technique, and the position of the transposon was mapped with restriction endonucleasas.
DW4 sequencing
Sequencing of M13 templates was performed using the dideoxy chain termination method (Sanger et ai. 1977) . M13-based primers were used initially, but for subsequent reactions, oligonudeotide primers were synthesized. Primer extension was catalysed by Sequenase {US Biochemical). DNA and protein sequences were analysed using Microgenie and MacVector software. Searches of the National Library of Medicine Protein Data Bank were supported by both of these software packages.
